|Aegis Capital Corp.||Robert LeBoyer||(646) 502-2494 | email@example.com|
|Maxim Group||Jason McCarthy, Ph.D.||(212) 895-3556 | firstname.lastname@example.org|
|SeeThruEquity||Brandon Primack, CFA||(646) 495-0939 | email@example.com|
|S&P Capital IQ||Mark Schwiebert||(888) 806-5541 | firstname.lastname@example.org|
|Zacks Investment Research||David Bautz, Ph.D.||(312) 265-9471 | email@example.com|
Matinas BioPharma Holdings, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Matinas BioPharma Holdings, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Matinas BioPharma Holdings, Inc. or its management. Matinas BioPharma Holdings, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.